Literature DB >> 3931523

Smoking does not reduce the functional activity of serum alpha-1-proteinase inhibitor. An epidemiologic study of 719 healthy men.

J Lellouch, J R Claude, J P Martin, G Orssaud, D Zaoui, J G Bieth.   

Abstract

The present study was aimed at testing the hypothesis that smoking, the major risk factor for the development of pulmonary emphysema, impairs the functional activity of alpha 1-proteinase inhibitor (alpha 1-antitrypsin). We used a population of 719 apparently healthy subjects. The serum concentrations of immunoreactive and functionally active alpha 1-proteinase inhibitor were measured by radial immunodiffusion and inhibition of porcine pancreatic elastase, respectively. Both the immunoreactive and functionally active levels of serum alpha 1-proteinase inhibitor were found to increase with tobacco consumption, but the ratio between the 2 concentrations was independent of smoking. Smoking does not, therefore, impair the functional activity of alpha1-proteinase inhibitor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931523     DOI: 10.1164/arrd.1985.132.4.818

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  3 in total

1.  The use of monoclonal antibodies to distinguish several chemically modified forms of human alpha 1-proteinase inhibitor.

Authors:  X J Zhu; S K Chan
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

2.  Alpha 1-proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema.

Authors:  G Trefz; J Schliesser; B Heck; V Schulz; W Ebert
Journal:  Clin Investig       Date:  1992 Mar-Apr

3.  Relation of serum elastin peptide concentration to age, FEV1, smoking habits, alcohol consumption, and protease inhibitor phenotype: an epidemiological study in working men.

Authors:  C Frette; S M Wei; F Neukirch; R Sesboüé; J P Martin; M P Jacob; F Kauffmann
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.